- Home
- NTHI vs JELD Comparison
NTHI vs JELD Comparison
Compare NTHI & JELD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NTHI | JELD |
|---|---|---|
| Founded | 2008 | 1960 |
| Country | United States | United States |
| Employees | 5 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Forest Products |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.1M | 138.7M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | NTHI | JELD |
|---|---|---|
| Price | $4.27 | $1.73 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 6 |
| Target Price | ★ $15.00 | $3.43 |
| AVG Volume (30 Days) | 51.0K | ★ 1.4M |
| Earning Date | 05-19-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,211,181,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.06 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.20 | $0.93 |
| 52 Week High | $12.99 | $6.98 |
Technical Indicators
Market Signals| Indicator | NTHI | JELD |
|---|---|---|
| Relative Strength Index (RSI) | 37.84 | 49.40 |
| Support Level | $3.87 | $1.70 |
| Resistance Level | $5.90 | $2.15 |
| Average True Range (ATR) | 0.42 | 0.19 |
| MACD | -0.04 | -0.03 |
| Stochastic Oscillator | 16.67 | 41.28 |
Price Performance
Historical ComparisonAbout NTHI NeOnc Technologies Holdings Inc.
NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.
About JELD JELD-WEN Holding Inc.
JELD-WEN Holding Inc is engaged in door and window manufacturing. The company designs, produces, and distributes interior and exterior building products, offering a selection of doors, windows, walls, and related products. The products are used in the new construction of residential and non-residential buildings. The firm's operating segments are North America, and Europe. It generates a majority of its revenue from North America.